Khaberni - Recent scientific studies suggest a significant shift in understanding the mechanisms of brain function, which could open the door to more precise treatments for mental health disorders, such as anxiety, depression, post-traumatic stress disorder, by focusing on a type of brain cell known as astrocytes.
Psychiatric medicine has focused for decades on neurons as the primary drivers of brain functions, yet the outcomes of treatments have been limited. However, recent studies have revealed that astrocytes, previously regarded merely as supporting cells, play a pivotal role in regulating neural signals, especially at the synapses between cells.
Research using advanced molecular biology techniques has shown that these cells are directly involved in learning, memory, and emotion regulation processes. In the amygdala, which is associated with fear, it was observed that astrocytes are active during the formation of fear memories, and scientists have been able to modify organisms' responses to traumatic events by controlling the activity of these cells.
Another advantage of these cells lies in their capability for precise targeting, as they carry distinctive proteins that vary across different brain regions. For example, the protein “NFIA” is particularly found in astrocytes within the hippocampus, allowing the development of drugs that target specific areas without affecting the rest of the body, potentially reducing the common side effects of current psychiatric medications.
In a significant development, studies have also revealed differences in the behavior of these cells between males and females, which may explain the higher rates of some mental disorders in women, and open the door to gender-specific treatments.
Researchers are currently working on developing drugs that directly target astrocytes, including an experimental drug known as KDS2010, which aims to reduce intrusive memories associated with trauma.
Although transitioning from animal trials to human subjects still poses a challenge, scientists believe that these cells could become the focus of the next generation of mental health treatments.
